Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

New insights into the secretory functions of brown adipose tissue.

Villarroya J, Cereijo R, Gavaldà-Navarro A, Peyrou M, Giralt M, Villarroya F.

J Endocrinol. 2019 Aug 1. pii: JOE-19-0295.R1. doi: 10.1530/JOE-19-0295. [Epub ahead of print] Review.

PMID:
31419785
2.

Sacubitril/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation.

Mochel JP, Teng CH, Peyrou M, Giraudel J, Danhof M, Rigel DF.

Eur J Pharm Sci. 2019 Feb 1;128:103-111. doi: 10.1016/j.ejps.2018.11.037. Epub 2018 Nov 30.

PMID:
30508581
3.

CXCL14, a Brown Adipokine that Mediates Brown-Fat-to-Macrophage Communication in Thermogenic Adaptation.

Cereijo R, Gavaldà-Navarro A, Cairó M, Quesada-López T, Villarroya J, Morón-Ros S, Sánchez-Infantes D, Peyrou M, Iglesias R, Mampel T, Turatsinze JV, Eizirik DL, Giralt M, Villarroya F.

Cell Metab. 2018 Nov 6;28(5):750-763.e6. doi: 10.1016/j.cmet.2018.07.015. Epub 2018 Aug 16.

4.

Brown Adipokines.

Villarroya F, Gavaldà-Navarro A, Peyrou M, Villarroya J, Giralt M.

Handb Exp Pharmacol. 2019;251:239-256. doi: 10.1007/164_2018_119.

PMID:
29675584
5.

The Lives and Times of Brown Adipokines.

Villarroya F, Gavaldà-Navarro A, Peyrou M, Villarroya J, Giralt M.

Trends Endocrinol Metab. 2017 Dec;28(12):855-867. doi: 10.1016/j.tem.2017.10.005. Epub 2017 Nov 4. Review.

PMID:
29113711
6.

The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes.

Quesada-López T, Cereijo R, Turatsinze JV, Planavila A, Cairó M, Gavaldà-Navarro A, Peyrou M, Moure R, Iglesias R, Giralt M, Eizirik DL, Villarroya F.

Nat Commun. 2016 Nov 17;7:13479. doi: 10.1038/ncomms13479.

7.

Oncostatin m impairs brown adipose tissue thermogenic function and the browning of subcutaneous white adipose tissue.

Sánchez-Infantes D, Cereijo R, Peyrou M, Piquer-Garcia I, Stephens JM, Villarroya F.

Obesity (Silver Spring). 2017 Jan;25(1):85-93. doi: 10.1002/oby.21679. Epub 2016 Oct 5.

8.

Transcriptional regulation of the uncoupling protein-1 gene.

Villarroya F, Peyrou M, Giralt M.

Biochimie. 2017 Mar;134:86-92. doi: 10.1016/j.biochi.2016.09.017. Epub 2016 Oct 5. Review.

PMID:
27693079
9.

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.

Jueliger S, Lyons J, Cannito S, Pata I, Pata P, Shkolnaya M, Lo Re O, Peyrou M, Villarroya F, Pazienza V, Rappa F, Cappello F, Azab M, Taverna P, Vinciguerra M.

Epigenetics. 2016 Oct 2;11(10):709-720. doi: 10.1080/15592294.2016.1214781. Epub 2016 Sep 20.

10.

Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease.

Sanchez-Pareja A, Clément S, Peyrou M, Spahr L, Negro F, Rubbia-Brandt L, Foti M.

World J Gastroenterol. 2016 Apr 14;22(14):3735-45. doi: 10.3748/wjg.v22.i14.3735.

11.

Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.

Mochel JP, Fink M, Peyrou M, Soubret A, Giraudel JM, Danhof M.

Pharm Res. 2015 Jun;32(6):1931-46. doi: 10.1007/s11095-014-1587-9. Epub 2014 Dec 2.

PMID:
25446774
12.

Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice.

Peyrou M, Bourgoin L, Poher AL, Altirriba J, Maeder C, Caillon A, Fournier M, Montet X, Rohner-Jeanrenaud F, Foti M.

J Hepatol. 2015 Feb;62(2):421-9. doi: 10.1016/j.jhep.2014.09.012. Epub 2014 Sep 16.

PMID:
25234947
13.

Influence of feeding schedules on the chronobiology of renin activity, urinary electrolytes and blood pressure in dogs.

Mochel JP, Fink M, Bon C, Peyrou M, Bieth B, Desevaux C, Deurinck M, Giraudel JM, Danhof M.

Chronobiol Int. 2014 Jun;31(5):715-30. doi: 10.3109/07420528.2014.897711. Epub 2014 Mar 21.

PMID:
24654920
14.

Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats.

Roberts ES, Vanlare KA, Strehlau G, Peyrou M, Roycroft LM, King S.

J Vet Pharmacol Ther. 2014 Apr;37(2):161-8. doi: 10.1111/jvp.12081. Epub 2013 Oct 18.

15.

Statins may protect against hepatocellular carcinoma development in patients infected with hepatitis C virus, but what are the mechanisms?

Clément S, Peyrou M, Foti M, Negro F.

J Clin Oncol. 2013 Nov 10;31(32):4160-1. doi: 10.1200/JCO.2013.51.0354. Epub 2013 Sep 30. No abstract available.

PMID:
24081939
16.

Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology.

Mochel JP, Fink M, Peyrou M, Desevaux C, Deurinck M, Giraudel JM, Danhof M.

Chronobiol Int. 2013 Nov;30(9):1144-59. doi: 10.3109/07420528.2013.807275. Epub 2013 Aug 9.

PMID:
23931032
17.

Population pharmacokinetic analysis of blood concentrations of robenacoxib in dogs with osteoarthritis.

Fink M, Letellier I, Peyrou M, Mochel JP, Jung M, King JN, Gruet P, Giraudel JM.

Res Vet Sci. 2013 Oct;95(2):580-7. doi: 10.1016/j.rvsc.2013.04.021. Epub 2013 May 31.

PMID:
23726662
18.

PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism.

Peyrou M, Clément S, Maier C, Bourgoin L, Branche E, Conzelmann S, Kaddai V, Foti M, Negro F.

J Hepatol. 2013 Sep;59(3):420-6. doi: 10.1016/j.jhep.2013.04.012. Epub 2013 Apr 23.

PMID:
23623999
19.

Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.

Rappa F, Greco A, Podrini C, Cappello F, Foti M, Bourgoin L, Peyrou M, Marino A, Scibetta N, Williams R, Mazzoccoli G, Federici M, Pazienza V, Vinciguerra M.

PLoS One. 2013;8(1):e54458. doi: 10.1371/journal.pone.0054458. Epub 2013 Jan 23. Erratum in: PLoS One. 2013;8(3). doi:10.1371/annotation/b456329c-02fa-4055-afb8-2090cec17da6.

20.

PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.

Peyrou M, Ramadori P, Bourgoin L, Foti M.

PPAR Res. 2012;2012:757803. Epub 2012 Sep 13.

21.

Capturing the dynamics of systemic Renin-Angiotensin-Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs.

Mochel JP, Peyrou M, Fink M, Strehlau G, Mohamed R, Giraudel JM, Ploeger B, Danhof M.

J Vet Pharmacol Ther. 2013 Apr;36(2):174-80. doi: 10.1111/j.1365-2885.2012.01406.x. Epub 2012 May 8.

PMID:
22568394
22.

Validation of a dried blood spot LC-MS/MS approach for cyclosporin A in cat blood: comparison with a classical sample preparation.

Mohamed R, Mercolini L, Cuennet-Cosandey S, Chavent J, Raggi MA, Peyrou M.

J Pharm Biomed Anal. 2012 Jul;66:298-305. doi: 10.1016/j.jpba.2012.03.049. Epub 2012 Apr 2.

PMID:
22522039
23.

Challenges obtaining a biowaiver for topical veterinary dosage forms.

Baynes R, Riviere J, Franz T, Monteiro-Riviere N, Lehman P, Peyrou M, Toutain PL.

J Vet Pharmacol Ther. 2012 Apr;35 Suppl 1:103-14. doi: 10.1111/j.1365-2885.2012.01381.x.

PMID:
22413798
24.

Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats.

Deblon N, Bourgoin L, Veyrat-Durebex C, Peyrou M, Vinciguerra M, Caillon A, Maeder C, Fournier M, Montet X, Rohner-Jeanrenaud F, Foti M.

Br J Pharmacol. 2012 Apr;165(7):2325-40. doi: 10.1111/j.1476-5381.2011.01716.x.

25.

Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets.

Clément S, Peyrou M, Sanchez-Pareja A, Bourgoin L, Ramadori P, Suter D, Vinciguerra M, Guilloux K, Pascarella S, Rubbia-Brandt L, Negro F, Foti M.

Hepatology. 2011 Jul;54(1):38-49. doi: 10.1002/hep.24340.

PMID:
21465511
26.

Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis.

Silber HE, Burgener C, Letellier IM, Peyrou M, Jung M, King JN, Gruet P, Giraudel JM.

Pharm Res. 2010 Dec;27(12):2633-45. doi: 10.1007/s11095-010-0262-z. Epub 2010 Oct 5.

PMID:
20922466
27.

PTEN in liver diseases and cancer.

Peyrou M, Bourgoin L, Foti M.

World J Gastroenterol. 2010 Oct 7;16(37):4627-33.

28.

CD4 dimerization requires two cysteines in the cytoplasmic domain of the molecule and occurs in microdomains distinct from lipid rafts.

Fournier M, Peyrou M, Bourgoin L, Maeder C, Tchou I, Foti M.

Mol Immunol. 2010 Oct;47(16):2594-603. doi: 10.1016/j.molimm.2010.06.010. Epub 2010 Aug 23.

PMID:
20739067
29.

PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer.

Peyrou M, Bourgoin L, Foti M.

Dig Dis. 2010;28(1):236-46. doi: 10.1159/000282095. Epub 2010 May 7. Review.

PMID:
20460918
30.

Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver.

Baertschiger RM, Serre-Beinier V, Morel P, Bosco D, Peyrou M, Clément S, Sgroi A, Kaelin A, Buhler LH, Gonelle-Gispert C.

PLoS One. 2009 Aug 17;4(8):e6657. doi: 10.1371/journal.pone.0006657.

31.

Xanthomonas axonopodis pv. citri enters the VBNC state after copper treatment and retains its virulence.

del Campo R, Russi P, Mara P, Mara H, Peyrou M, de León IP, Gaggero C.

FEMS Microbiol Lett. 2009 Sep;298(2):143-8. doi: 10.1111/j.1574-6968.2009.01709.x. Epub 2009 Jun 26.

32.

Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN.

Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, Foti M.

J Hepatol. 2009 Jun;50(6):1132-41. doi: 10.1016/j.jhep.2009.01.027. Epub 2009 Apr 1.

PMID:
19398230
33.

Calpain inhibition but not reticulum endoplasmic stress preconditioning protects rat kidneys from p-aminophenol toxicity.

Peyrou M, Hanna PE, Cribb AE.

Toxicol Sci. 2007 Sep;99(1):338-45. Epub 2007 Jun 12.

PMID:
17567592
34.

Cisplatin, gentamicin, and p-aminophenol induce markers of endoplasmic reticulum stress in the rat kidneys.

Peyrou M, Hanna PE, Cribb AE.

Toxicol Sci. 2007 Sep;99(1):346-53. Epub 2007 Jun 12.

PMID:
17567590
35.
36.
37.

Connexin36 and pancreatic beta-cell functions.

Nlend RN, Michon L, Bavamian S, Boucard N, Caille D, Cancela J, Charollais A, Charpantier E, Klee P, Peyrou M, Populaire C, Zulianello L, Meda P.

Arch Physiol Biochem. 2006 Apr;112(2):74-81. Review.

PMID:
16931449
38.

Involvement of gap junctional communication in secretion.

Michon L, Nlend Nlend R, Bavamian S, Bischoff L, Boucard N, Caille D, Cancela J, Charollais A, Charpantier E, Klee P, Peyrou M, Populaire C, Zulianello L, Meda P.

Biochim Biophys Acta. 2005 Dec 20;1719(1-2):82-101. Epub 2005 Nov 18. Review.

39.

The endoplasmic reticulum in xenobiotic toxicity.

Cribb AE, Peyrou M, Muruganandan S, Schneider L.

Drug Metab Rev. 2005;37(3):405-42. Review.

PMID:
16257829
40.

Population pharmacokinetics of marbofloxacin in horses: preliminary analysis.

Peyrou M, Doucet MY, Vrins A, Concordet D, Schneider M, Bousquet-Mélou A.

J Vet Pharmacol Ther. 2004 Oct;27(5):283-8.

PMID:
15500564
41.

[Evolution of bacterial resistance to certain antibacterial agents in horses in a veterinary hospital].

Peyrou M, Higgins R, Lavoie JP.

Can Vet J. 2003 Dec;44(12):978-81. French.

Supplemental Content

Loading ...
Support Center